SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR and ONLY ADVR
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kingfisher who wrote (89)9/26/2000 10:09:38 PM
From: Bernie Bildman  Read Replies (1) of 278
 
I am going to assume production will be at Freeport. To delay IND application a considerable length of time JUST for the capacity to manufacture at Yonkers might just as well spell disaster - if that keeps the company from filing for another LONG period of time into next year.

I have to believe the main focus has to be getting one IND in and then if they want to use Yonkers, they will have more time.

Whether ADVR wants to acknowledge it or not, there is a time factor her. At some point in time, there WILL be another company that produces a drug similar to Product R. There is more than one way to skin a cat, and they need to get THEIR method in place before anything like happens.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News